{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:14:02Z","timestamp":1788484442361,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Progn Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Rapid treatment of stroke improves outcomes, but accurate early recognition can be challenging. Between 20 and 40% of patients suspected to have stroke by ambulance and emergency department staff later receive a non-stroke \u2018mimic\u2019 diagnosis after stroke specialist investigation. This early diagnostic uncertainty results in displacement of mimic patients from more appropriate services, inappropriate demands on stroke specialist resources and delayed access to specialist therapies for stroke patients. Blood purine concentrations rise rapidly during hypoxic tissue injury, which is a key mechanism of damage during acute stroke but is not typical in mimic conditions. A portable point of care fingerprick test has been developed to measure blood purine concentration which could be used to triage patients experiencing suspected stroke symptoms into those likely to have a non-stroke mimic condition and those likely to have true stroke. This study is evaluating test performance for identification of stroke mimic conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Design: prospective observational cohort study<\/jats:p>\n                <jats:p>Setting: regional UK ambulance and acute stroke services<\/jats:p>\n                <jats:p>Participants: a convenience series of two populations will be tested: adults with a label of suspected stroke assigned (and tested) by attending ambulance personnel and adults with a label of suspected stroke assigned at hospital (who have not been tested by ambulance staff).<\/jats:p>\n                <jats:p>Index test: SMARTChip Purine assay<\/jats:p>\n                <jats:p>Reference standard tests: expert clinician opinion informed by brain imaging and\/or other investigations will assign the following diagnoses which constitute the suspected stroke population: ischaemic stroke, haemorrhagic stroke, TIA and stroke mimic conditions.<\/jats:p>\n                <jats:p>Sample size: ambulance population (powered for mimic sensitivity) 935 participants; hospital population (powered for mimic specificity) 377 participants.<\/jats:p>\n                <jats:p>Analyses: area under the receiver operating curve (ROC) and optimal sensitivity, specificity, and negative and positive predictive values for identification of mimic conditions. Optimal threshold for the ambulance population will maximise sensitivity, minimum 80%, and aim to keep specificity above 70%. Optimal threshold for the hospital population will maximise specificity, minimum 80%, and aim to keep sensitivity above 70%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The results from this study will determine how accurately the SMARTChip purine assay test can identify stroke mimic conditions within the suspected stroke population. If acceptable performance is confirmed, deployment of the test in ambulances or emergency departments could enable more appropriate direction of patients to stroke or non-stroke services.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Registered with ISRCTN (identifier: ISRCTN22323981) on 13\/02\/2019 <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.isrctn.com\/ISRCTN22323981\">http:\/\/www.isrctn.com\/ISRCTN22323981<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41512-021-00098-3","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:18:57Z","timestamp":1621495137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Purines for Rapid Identification of Stroke Mimics (PRISM): study protocol for a diagnostic accuracy study"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-4655","authenticated-orcid":false,"given":"Lisa","family":"Shaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Graziadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Lendrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Roffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher I.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"98_CR1","volume-title":"Exective summary Part 2: societal costs of stroke in the next 20 years and potential returns from increased spending on research","author":"A Patel","year":"2017","unstructured":"Patel A, Berdunov V, King D, Quayyum Z, Wittenberg R, Knapp M. Current, future and avoidable costs of stroke in the UK. In: Exective summary Part 2: societal costs of stroke in the next 20 years and potential returns from increased spending on research. London: Stroke Association; 2017."},{"key":"98_CR2","unstructured":"Stroke Unit Trialists Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev. 2013:CD000197."},{"key":"98_CR3","unstructured":"National Institute for Health and Care Excellence. Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122). NICE technology appraisal guidance 264; 2012."},{"key":"98_CR4","doi-asserted-by":"crossref","unstructured":"Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2014:CD000213.","DOI":"10.1002\/14651858.CD000213.pub3"},{"issue":"12","key":"98_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CBLM, Dippel DW, et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA. 2016;316(12):1279\u201388. https:\/\/doi.org\/10.1001\/jama.2016.13647.","journal-title":"JAMA."},{"key":"98_CR6","unstructured":"NHS England. The NHS Long Term Plan. www.longtermplan.nhs.uk; 2019."},{"key":"98_CR7","unstructured":"Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke 5th Edition. Royal College of Physicians. 2016."},{"issue":"1","key":"98_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/01.STR.0000044170.46643.5E","volume":"34","author":"J Harbison","year":"2003","unstructured":"Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003;34(1):71\u20136. https:\/\/doi.org\/10.1161\/01.STR.0000044170.46643.5E.","journal-title":"Stroke."},{"issue":"2","key":"98_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4997\/JRCPE.2013.205","volume":"43","author":"LM Gibson","year":"2013","unstructured":"Gibson LM, Whiteley W. The differential diagnosis of suspected stroke: a systematic review. J R Coll Physicians Edinb. 2013;43(2):114\u20138. https:\/\/doi.org\/10.4997\/JRCPE.2013.205.","journal-title":"J R Coll Physicians Edinb."},{"issue":"11","key":"98_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1136\/emermed-2015-205197","volume":"33","author":"M Rudd","year":"2016","unstructured":"Rudd M, Buck D, Ford GA, Price CI. A systematic review of stroke recognition instruments in hospital and prehospital settings. EMJ. 2016;33(11):818\u201322. https:\/\/doi.org\/10.1136\/emermed-2015-205197.","journal-title":"EMJ."},{"key":"98_CR11","unstructured":"Clinical Effectiveness and Evaluation Unit Royal College of Physicians. The Sentinel Stroke National Audit Programme (SSNAP). https:\/\/www.rcplondon.ac.uk\/projects\/ssnap-clinical-audit."},{"key":"98_CR12","unstructured":"Unpublished data from Salford Royal Infirmary."},{"issue":"3","key":"98_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.neurol.2016.02.003","volume":"172","author":"I Maestrini","year":"2016","unstructured":"Maestrini I, Ducroquet A, Moulin S, Leys D, Cordonnier C, Bordet R. Blood biomarkers in the early stage of cerebral ischemia. Rev Neurol. 2016;172(3):198\u2013219. https:\/\/doi.org\/10.1016\/j.neurol.2016.02.003.","journal-title":"Rev Neurol"},{"key":"98_CR14","first-page":"2902","volume":"39","author":"W Whitely","year":"2008","unstructured":"Whitely W, Tseng M, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke. Syst Rev. 2008;39:2902\u2013090.","journal-title":"Syst Rev."},{"issue":"3","key":"98_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s13311-011-0050-4","volume":"8","author":"GC Jickling","year":"2011","unstructured":"Jickling GC, Sharp FR. Blood biomarkers of ischemic stroke. Neurotherapeutics. 2011;8(3):349\u201360. https:\/\/doi.org\/10.1007\/s13311-011-0050-4.","journal-title":"Neurotherapeutics"},{"issue":"5","key":"98_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/jcbfm.1989.87","volume":"9","author":"L Hillered","year":"1989","unstructured":"Hillered L, Hallstrom A, Segersvard S, Persson L, Ungerstedt U. Dynamics of extracellular metabolites in the striatum after middle cerebral artery occlusion in the rat monitored by intracerebral microdialysis. J Cereb Blood Flow Metab. 1989;9(5):607\u201316. https:\/\/doi.org\/10.1038\/jcbfm.1989.87.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl 1","key":"98_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11302-011-9273-4","volume":"8","author":"N Dale","year":"2012","unstructured":"Dale N, Frenguelli BG. Measurement of purine release with microelectrode biosensors. Purinergic Signal. 2012;8(Suppl 1):27\u201340. https:\/\/doi.org\/10.1007\/s11302-011-9273-4.","journal-title":"Purinergic Signal"},{"issue":"4","key":"98_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11302-017-9578-z","volume":"13","author":"F Tian","year":"2017","unstructured":"Tian F, Bibi F, Dale N, Imray CHE. Blood purine measurements as a rapid real-time indicator of reversible brain ischaemia. Purinergic Signal. 2017;13(4):521\u20138. https:\/\/doi.org\/10.1007\/s11302-017-9578-z.","journal-title":"Purinergic Signal"},{"issue":"2","key":"98_CR19","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11302-019-09647-4","volume":"15","author":"N Dale","year":"2019","unstructured":"Dale N, Tian F, Sagoo R, Phillips N, Imray C, Roffe C. Point-of-care measurements reveal release of purines into venous blood of stroke patients. Purinergic Signal. 2019;15(2):237\u201346. https:\/\/doi.org\/10.1007\/s11302-019-09647-4.","journal-title":"Purinergic Signal"},{"issue":"7","key":"98_CR20","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","volume":"20","author":"T Brott","year":"1989","unstructured":"Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864\u201370. https:\/\/doi.org\/10.1161\/01.STR.20.7.864.","journal-title":"Stroke."},{"issue":"4","key":"98_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1747-4949.2008.00221.x","volume":"3","author":"V Puetz","year":"2008","unstructured":"Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, et al. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke. 2008;3(4):230\u20136. https:\/\/doi.org\/10.1111\/j.1747-4949.2008.00221.x.","journal-title":"Int J Stroke."},{"issue":"9216","key":"98_CR22","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(00)02237-6","volume":"355","author":"PA Barber","year":"2000","unstructured":"Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355(9216):1670\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(00)02237-6.","journal-title":"Lancet."},{"issue":"8756","key":"98_CR23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","volume":"337","author":"J Bamford","year":"1991","unstructured":"Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337(8756):1521\u20136. https:\/\/doi.org\/10.1016\/0140-6736(91)93206-O.","journal-title":"Lancet."},{"issue":"2","key":"98_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/neurintsurg-2013-010665","volume":"6","author":"M Goyal","year":"2014","unstructured":"Goyal M, Fargen KM, Turk AS, Mocco J, Liebeskind DS, Frei D, et al. 2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials. J Neurointervent Surg. 2014;6(2):83\u20136. https:\/\/doi.org\/10.1136\/neurintsurg-2013-010665.","journal-title":"J Neurointervent Surg."},{"issue":"2","key":"98_CR25","first-page":"119","volume":"52","author":"A Agresti","year":"1998","unstructured":"Agresti A, Coull BJ. Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions. The American Statistician. 1998;52(2):119\u201326.","journal-title":"The American Statistician."},{"issue":"2","key":"98_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/sim.6787","volume":"35","author":"GS Collins","year":"2016","unstructured":"Collins GS, Oguundimu EO, Altman DG. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Statistics Med. 2016;35(2):214\u201326. https:\/\/doi.org\/10.1002\/sim.6787.","journal-title":"Statistics Med"},{"key":"98_CR27","doi-asserted-by":"publisher","first-page":"h5527","DOI":"10.1136\/bmj.h5527","volume":"351","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527.","journal-title":"BMJ."},{"issue":"9","key":"98_CR28","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1161\/STROKEAHA.117.017076","volume":"48","author":"A Bustamante","year":"2017","unstructured":"Bustamante A, L\u00f3pez-Cancio E, Pich S, Penalba A, Giralt D, Garc\u00eda-Berrocoso T, et al. Blood biomarkers for the early diagnosis of stroke: the Stroke-Chip Study. Stroke. 2017;48(9):2419\u201325. https:\/\/doi.org\/10.1161\/STROKEAHA.117.017076.","journal-title":"Stroke."}],"container-title":["Diagnostic and Prognostic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-021-00098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41512-021-00098-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-021-00098-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T07:22:18Z","timestamp":1621495338000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnprognres.biomedcentral.com\/articles\/10.1186\/s41512-021-00098-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["98"],"URL":"https:\/\/doi.org\/10.1186\/s41512-021-00098-3","relation":{},"ISSN":["2397-7523"],"issn-type":[{"value":"2397-7523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"3 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical (NRES Committee North East-Newcastle & North Tyneside 1, reference: 18\/NE\/0307) and NHS approvals have been granted. Written informed consent is obtained for patient participation as detailed above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LS and CP receive non-financial support from Cerebrotech Medical Systems Inc and a grant from Innovate UK.ND is CSO of Sarissa Biomedical and has a financial interest in this company. He is also an inventor on patents linking purine measurement to ischaemic disease.All other authors declare that they have no relevant competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}